首页> 外文OA文献 >Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis

【2h】

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis

机译：骨质周转标志物在绝经后骨质疏松症患者中检测治疗的临床效用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
K.E. Naylor; E.V. McCloskey; R.M. Jacques; N.F.A. Peel; M.A. Paggiosi; F. Gossiel; J.S. Walsh; R. Eastell;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis [J] . Naylor K. E., Mccloskey E. V, Jacques R. M., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2019,第4期

机译：骨质周转标志物在绝经后骨质疏松症患者中检测治疗的临床效用
2. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density [J] . Naylor K. E., Bradburn M., Paggiosi M. A., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2018,第6期

机译：在骨质周转标志物和骨密度上停止口服双膦酸盐治疗的影响骨质骨质疏松症
3. Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. [J] . Funck Brentano T, Biver E, Chopin F, Seminars in Arthritis and Rheumatism . 2011,第2期

机译：血清骨转换标志物在绝经后骨质疏松症治疗监测中的临床应用：系统综述。
4. Modeling the risk of osteopenia and osteoporosis in postmenopausal women with type 2 diabetes on the sets of clinical and immunogenetic parameters [C] . O. N. Fazullina, V. V. Klimontov, V. I. Konenkov, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：根据临床和免疫遗传学参数对绝经后2型糖尿病妇女骨质疏松和骨质疏松的风险进行建模
5. The relationship of vitamin D and selected nutrient intakes, sex hormone binding globulin and markers of bone turnover to bone mineral density in exercising and non-exercising postmenopausal women taking or not taking HRT. [D] . Sparks, Patricia Lynne. 2001

机译：在接受或不接受HRT的运动和非运动绝经后妇女中，维生素D与选定的营养摄入量，性激素结合球蛋白以及骨转换标志与骨矿物质密度的关系。
6. Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club [O] . P Bergmann, J-J Body, S Boonen, -1

机译：在骨质疏松症的双膦酸盐治疗选择和监测中使用骨转换生化标志物的循证指南：比利时骨俱乐部的共识性文件
7. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density [O] . K. E. Naylor, M. Bradburn, M. A. Paggiosi, 2018

机译：在骨质周转标志物和骨密度上停止口服双膦酸盐治疗的影响骨质骨质疏松症

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis

著录项

引文网络

相似文献

相关主题

期刊订阅